author-photo

Eli Zuckerman

University of Southern California

44

Papers

1670

Citations

Citation Trend

Filter By

Papers (30) Sort By

Journal Conference Others

THU-198-Efficacy and safety of glecaprevir/pibrentasvir treatment for 8 weeks in treatment-naive patients with chronic hepatitis C virus infection without cirrhosis or with compensated cirrhosis: Analysis of data pooled from phase 2 and 3 studies

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (1)
THU-200-The Real-Eorld Israeli experience of treating mild and severe chronic hepatitis C patients with elbasvir/grazoprevir: A large multi-center cohort study

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
THU-199-Awake the dormants: Barriers to access to care and cure in patients with chronic HCV infection

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

2019 The Lancet
Show All
- Source
- Cite
- Save
Citations (357)
ELABORATION AND TREATMENT DECISION IN INCIDENTAL SPLANCHNIC VEIN THROMBOSIS

2019 Harefuah
- Ayala Rozano Gorelick
- Eli Zuckerman
Show All
- Source
- Cite
- Save
Citations (0)
951 – Efficacy and Safety of Glecaprevir/Pibrentasvir Treatment for 8 Weeks in Treatment-Naïve Patients with Chronic Hepatitis C Virus Infection Without Cirrhosis Or with Compensated Cirrhosis: Analysis of Data Pooled from Phase 2 and 3 Studies

2019 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
SAT-154-Acute hemodynamic response to I.V propranolol during hepatic hemodynamic study in 26 cirrhotic patients with portal hypertention and nonbleeding esophageal varices. Correlation with esophageal bleeding and survival

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: real-life data

2019 Antiviral Therapy
Show All
- Source
- Cite
- Save
Citations (4)
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

2015 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (119)
Phase 2, Randomized, Open-Label Clinical Trials of the Efficacy and Safety of Grazoprevir and MK-3682 (NS5B Polymerase Inhibitor) with Either Elbasvir or MK-8408 (NS5A Inhibitor) in Patients with Chronic HCV GT1, 2 or 3 Infection (Part A of C-CREST-1 & 2)

2015 Hepatology
Show All
- Source
- Cite
- Save
Citations (6)